Mazdutide and Semaglutide Interaction

Avoid
Researched 95% confidence

Mazdutide and Semaglutide have a potentially harmful interaction with 95% confidence. Both are GLP-1 agonists; combining increases hypoglycemia and severe GI side effect risk. Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

Mazdutide

Dual GLP-1/Glucagon Receptor Agonist | Weight Loss & Diabetes

Dual agonist activation: GLP-1 stimulates insulin, suppresses glucagon, slows gastric emptying; Glucagon increases energy expenditure and thermogenesis while GLP-1 counteracts glucose-raising effects..

Half-life: 6-8 days Typical dose: Start 1.5-3mg weekly, titrate up to 6-9mg based on response weight loss, metabolic
insulin disruptingteratogenic
View full profile

Semaglutide

GLP-1 Receptor Agonist | Weight Loss & Diabetes

Mimics native GLP-1, binding to receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite via hypothalamic pathways..

Half-life: ~7 days (168 hours) Typical dose: 0.25mg starting, titrate to 1-2.4mg weekly weight loss, metabolic
glp1 receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (Mazdutide, Semaglutide). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (Mazdutide, Semaglutide). Monitor accordingly.

Frequently Asked Questions

Can I take Mazdutide with Semaglutide?

Combining Mazdutide with Semaglutide is not recommended. Both are GLP-1 agonists; combining increases hypoglycemia and severe GI side effect risk.

Is Mazdutide and Semaglutide safe together?

This combination carries significant risk. Both are GLP-1 agonists; combining increases hypoglycemia and severe GI side effect risk. Consult a healthcare professional before combining.

What are the interactions between Mazdutide and Semaglutide?

Both are GLP-1 agonists; combining increases hypoglycemia and severe GI side effect risk. This assessment has 95% confidence and is based on documented research data.

How should I time Mazdutide and Semaglutide?

Mazdutide has a half-life of 6-8 days and Semaglutide has a half-life of ~7 days (168 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Mazdutide vs Semaglutide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.